Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 43,168 shares at $7.82 ($338K) on 2026-01-06, disclosed to the SEC on 2026-01-07.
Seasonal sale ($338k) by President and CEO — this insider has traded RLAY in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2025-11-04 | $435K | — | Filing → |
| RLAY | SELL | 2025-07-10 | $438K | — | Filing → |